Personalized Airway Sensory Phenotyping in ENT Disorders

Abstract

Personalized airway sensory phenotyping is an emerging paradigm in otolaryngology that seeks to refine the diagnosis and management of ENT disorders by characterizing the unique sensory profiles of individual patients. This review synthesizes current knowledge on the epidemiology, pathophysiology, risk factors, clinical features, diagnostic approaches, and management strategies related to airway sensory phenotypes in ENT diseases. With an emphasis on recent advances, guideline recommendations, and the clinical implications of tailored phenotyping, the article provides a comprehensive overview for clinicians seeking to integrate precision medicine into practice.

Introduction

The heterogeneity of ear, nose, and throat (ENT) disorders presents a significant challenge in clinical management. Traditional classification systems often fail to capture the nuanced variations in sensory function that influence disease expression and therapeutic response. Personalized airway sensory phenotyping aims to bridge this gap by identifying individual differences in sensory neuron function, thus enabling more precise diagnosis and targeted interventions. This review explores the scientific underpinnings, clinical relevance, and future potential of this rapidly evolving field, with particular focus on conditions such as chronic rhinosinusitis, allergic rhinitis, and laryngeal hypersensitivity.

Epidemiology / Disease Burden

ENT disorders with significant airway sensory involvement, including chronic cough, nonallergic rhinitis, and laryngeal sensory neuropathy, affect millions globally. The prevalence of chronic rhinosinusitis alone is estimated at 11% in Western populations, with a substantial subset exhibiting aberrant sensory phenotypes. Airway sensory dysfunction contributes to symptom severity, health-related quality of life impairment, and increased healthcare utilization. Epidemiological studies underscore the need for refined phenotyping to address the unmet needs of these patient populations and to reduce the socioeconomic burden of refractory symptoms.

Pathophysiology

Airway sensory phenotyping centers on the functional diversity of afferent nerve fibers primarily the trigeminal and vagal pathways that mediate responses to mechanical, thermal, and chemical stimuli. In ENT disorders, aberrant activation or sensitization of these pathways leads to heightened symptom perception, such as hyperreactivity in chronic cough or enhanced nasal sensitivity in nonallergic rhinitis. Mechanistic insights from neurophysiology and molecular biology have revealed roles for transient receptor potential (TRP) channels, neurotrophic factors, and inflammatory mediators in modulating sensory neuron excitability. This mechanistic granularity forms the basis for personalized phenotyping and targeted interventions.

Risk Factors

Genetic predisposition, environmental exposures (e.g., pollutants, allergens), prior viral infections, and chronic inflammation are recognized risk factors for abnormal sensory phenotypes in ENT diseases. Comorbidities such as asthma, gastroesophageal reflux, and anxiety disorders may potentiate or modify sensory dysfunction. Recent studies also implicate age, sex, and occupational exposures as important determinants, highlighting the multifactorial basis of airway sensory phenotypic variability.

Clinical Features

Patients with aberrant airway sensory phenotypes often present with disproportionate or refractory symptoms, including chronic cough, throat clearing, globus sensation, nasal hyperreactivity, and paradoxical vocal fold movement. These features may persist despite conventional therapy and are frequently accompanied by heightened sensitivity to innocuous stimuli, such as odors, temperature changes, or mechanical irritation. Accurate clinical characterization of sensory-driven symptoms is essential for effective phenotyping and management.

Diagnosis

Diagnostic approaches to airway sensory phenotyping integrate detailed clinical history, validated symptom questionnaires, and objective sensory testing. Tools such as nasal or laryngeal provocation tests, quantitative sensory testing (QST), and cough reflex sensitivity assays help delineate sensory profiles. Emerging biomarkers such as neuropeptide levels and TRP channel expression offer promise for further stratification. Multidisciplinary assessment, including input from allergists, pulmonologists, and neurologists, is often warranted in complex cases.

Treatment & Management

Management strategies are increasingly tailored to sensory phenotype, with interventions targeting underlying neural dysfunction. Pharmacologic options include neuromodulators (e.g., gabapentinoids, amitriptyline), topical anesthetics, and anti-inflammatory agents. Nonpharmacologic modalities such as speech therapy, desensitization protocols, and biofeedback are gaining traction. For select patients, addressing modifiable risk factors and comorbidities is crucial. Personalized management improves symptom control and reduces unnecessary escalation to invasive procedures.

Recent Advances / Emerging Therapies

Recent advances encompass the identification of novel molecular targets, such as TRP channel antagonists, and the development of precision diagnostic algorithms using artificial intelligence and machine learning. Clinical trials are evaluating the efficacy of biologics, targeted small molecules, and gene therapies for refractory sensory phenotypes. Digital health platforms and remote monitoring tools facilitate longitudinal phenotyping and individualized care pathways, marking a significant leap toward precision otolaryngology.

Guideline Recommendations

International guidelines increasingly recognize the importance of individualized sensory assessment in ENT disorders. The European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) and American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) advocate for the integration of sensory phenotyping in refractory cases. Recommendations emphasize multidisciplinary collaboration, use of validated diagnostic tools, and evidence-based selection of neuromodulatory therapies.

Conclusion

Personalized airway sensory phenotyping represents a transformative approach in the management of ENT disorders. By elucidating the mechanistic and clinical heterogeneity of sensory dysfunction, it enables clinicians to deliver targeted, effective, and patient-centered care. Ongoing research and advances in molecular diagnostics promise to further refine phenotyping paradigms and expand the therapeutic armamentarium. The integration of sensory phenotyping into routine practice holds the potential to significantly improve outcomes for individuals with complex and refractory ENT symptoms.